Listed GP Gimv has published its 2019/2020 financial year results, confirming a €2.50 dividend with the option to receive new shares, but reporting a negative 10.3% portfolio return in the wake of the coronavirus crisis.
Company has raised €20m so far over two funding rounds
HV Holtzbrinck and Lakestar also participate in the round for the dental technology startup
IK VIII held a final close in November 2016 with €1.85bn and was 87% deployed as of December 2019
With the GP's support, Bomi intends to pursue an intensive buy-and-build strategy